Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828711 · ClinicalTrials.gov registry record · Phase 2
Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor
A Phase 2 study of Cervical Ripening and Induction of Labor, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 374
- Enrollment target
- 11
- Study locations
NCT00828711 is a Phase 2 study of Cervical Ripening and Induction of Labor that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 374 participants, below the 424-participant average among 8 other Cervical Ripening trials with a reported enrollment target (12% lower). The trial reports 11 study locations across 8 states.
The verdict
NCT00828711, a Phase 2 study of Cervical Ripening and Induction of Labor, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 374 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this study is to assess the efficacy and safety of the 100, 150 and 200 mcg Misoprostol Vaginal Insert (MVI 100, MVI 150 and MVI 200) for women requiring cervical ripening and induction of labor.
Conditions Studied
Interventions
- DRUG MVI 200
- DRUG MVI 100
- DRUG MVI 150
Study Locations (11)
Arizona
- Precision Trials - Phoenix
- Tuscon Medical Center - Tucson
California
- Long Beach Memorial Medical Center - Long Beach
- UCI Medical Center - Orange
North Carolina
- Duke University Medical Center - Durham
- Forsyth Medical Center - Winston-Salem
New Mexico
- University of New Mexico Medical Center - Albuquerque
Pennsylvania
- Temple University Hospital - Philadelphia
South Carolina
- Greenville Hospital System - Greenville
Tennessee
- University of Tennesse Medical Center - Knoxville
Texas
- University of Texas Health Sciences Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 374 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00828711
The ClinicalTrials.gov registry entry for NCT00828711 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 374 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 424-participant average among 8 other Cervical Ripening trials with a reported enrollment target (12% lower). The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cervical Ripening appearing as the primary indexed condition, and to 3 interventions - of which MVI 200 is the first listed.
NCT00828711 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Arizona, California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00828711 about?
NCT00828711 is a clinical study titled "Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor". The purpose of this study is to assess the efficacy and safety of the 100, 150 and 200 mcg Misoprostol Vaginal Insert (MVI 100, MVI 150 and MVI 200) for women requiring cervical ripening and induction of labor.
What is the current status of trial NCT00828711?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 374 participants. The study started on 2009-04. Estimated completion is 2009-12.
What conditions does trial NCT00828711 study?
This clinical trial studies the following conditions: Cervical Ripening, Induction of Labor.
What interventions are being tested in trial NCT00828711?
The interventions under investigation include: MVI 200 (DRUG), MVI 100 (DRUG), MVI 150 (DRUG).
Who is sponsoring clinical trial NCT00828711?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00828711 being conducted?
This trial has 11 study locations across Arizona, California, New Mexico, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Ripening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)
COMPLETED · Phase 2
-
Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation
COMPLETED · Phase 2
-
Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor
COMPLETED · NA
-
Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening
COMPLETED · NA
-
Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin
COMPLETED · Phase 3
-
Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.